Concentrations of pro-hepcidin in serum of pregnant women and in umbilical cord blood;Steżenia pro-hepcydyny w surowicy kobiet cieżarnych oraz krwi pepowinowej

Ginekologia Polska

Volumn 79, Issue 11, 2008, Pages 754-757

  Chełchowska, Magdalena ^a   Światek, Ewa ^b   Ambroszkiewicz, Jadwiga ^a   Gajewska, Joanna ^a   Laskowska Klita, Teresa ^a   Leibschang, Jerzy ^c  

^a Instytutu Matki i Dziecka ^*  (Poland)

^b INSTITUTE OF MOTHER AND CHILD   (Poland)

^c Centralny Szpital Kliniczny Ministerstwa Spraw Wewn trznych   (Poland)

Author keywords

Pregnant women; Prop hepcidin; Umbilical cord blood

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; FERRITIN; PROHEPCIDIN; PROTEIN PRECURSOR; TRANSFERRIN;

ADULT; ARTICLE; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS BLOOD; HUMAN; POLAND; PREGNANCY; REFERENCE VALUE; TERM BIRTH;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITINS; FETAL BLOOD; HUMANS; MATERNAL-FETAL EXCHANGE; POLAND; PREGNANCY; PROTEIN PRECURSORS; REFERENCE VALUES; TERM BIRTH; TRANSFERRIN;

EID: 59349096146     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Park C, Valore E, Waring A, [et al.]. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001, 276, 7806-7810.
2. Nemeth E, Tuttle M, Powelson J, [et al.]. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004, 306, 2090-2093.
3. Lipiński P, Starzyński R. Regulacja ogólnoustrojowej homeostazy żelaza przez hepcydyne. Postepy Hig Med Dośw. 2004, 58, 65-73.
4. Rogalska M, Flisiak R. Hepcydyna - współczesny stan wiedzy. Diag Lab. 2007, 43, 295-301.
5. Nicolas G, Bennoun M, Porteu A, [et al.]. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002, 99, 4596-4601.
6. Pigeon C, Ilyin G, Courselaud B, [et al.]. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001, 7811-7819.
7. Kulaksiz H, Gehrke S, Janetzko A, [et al.] Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004, 53, 735-743.
8. Detivaud L, Nemeth E, Boudjema K, [et al.]. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood. 2005, 106, 746-748.
9. Nemeth E, Rivera S, Gabayan V, [et al.]. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004, 113, 1271-1276.
10. Andrews N. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004, 113, 1251-1253.
11. Nicolas G, Chauvet C, Viatte L, [et al.]. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002, 110, 1037-1044.
12. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003, 102, 783-788.
13. Taes Y, Wuyts B, Boelaert J, [et al.]. Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med. 2004, 42, 387-389.
14. Małyszko J, Małyszko J, Hryszko T, [et al.]. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am J Nephrol. 2005, 25, 586-590.
15. Zdziennicki A, Laudański T. Iron deficiency as a risk factor during the perinatal period. Ginekol Pol. 1996, 67, 301-303.
16. Ciok J, Leibschang J. The report of UNICEF/WHO joint consultation on iron deficiency anemia, Genewa 3-5 lutego 1999. Ginekol Pol. 1999, 70, 573-577.
17. Hadley K, Johnson K, Hunt J. Iron absorption by healthy women is not associated with either serum or urinary prohepcidin. Am J Clin Nutr. 2006, 84, 150-155.
18. Roe M, Spinks C, Heath A, [et al.]. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in man carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br J Nutr. 2007, 97, 544-549.
19. Ezeh C, Ugochukwu C, Weinstein J, [et al.]. Hepcidin, haemoglobin and ferritin levels in sickle cell anaemia. Eur J Haematol. 2005, 74, 86-88.
20. Millard K, Frazer D, Wilkins S, [et al.]. Changes in the expression of intestinal iron transport and hepatic regulatory molecules explain the enhanced iron absorption associated with pregnancy in the rat. Gut. 2004, 53, 665-660.
21. Laskowska-Klita T, Chełchowska M., Ambroszkiewicz J, [et al.]. Serum pro-hepcidin and iron markers during uncomplicated pregnancy. Eur J Obstet Gynecol Reprod Biol. 2007, 130, 273-274.
22. Balogh A, Szabo M, Kelen D, [et al.]. Prohepcidin levels during human perinatal adaptation. Pediatr Hematol Oncol. 2007, 24, 361-368.
23. Brookes M, Sharma N, Tselepis C, [et al.]. Serum pro-hepcidin: measuring active hepcidin or a non-functional precursor? Gut. 2005, 54, 169-170.